Mi Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mi Liu has a total of 215 co-authors. Here are the top co-authors by number of shared publications:
Jingying Zhou
School of Acupuncture-moxibustion, Tuina and Rehabilitation, Changsha, China
10 shared publications- Xiao-Rong Chang
School of Acupuncture-moxibustion, Tuina and Rehabilitation, Hunan University of Chinese Medicine, Changsha, China
8 shared publications Haolong He
7 shared publications- Shulin Xiong
Hunan University of Chinese Medicine, Changsha, China
7 shared publications Haihua Xie
Hunan University of Chinese Medicine, Changsha, China
6 shared publicationsSihui Cao
College of Acupuncture and Tuina and Rehabilitation, Hunan University of Chinese Medicine
6 shared publications
Latest Publications
- Open Access
- 22 August 2026
- Published by Springer Nature in Systematic Reviews
- Vol. 15 (1) , 238
Effectiveness of acupuncture combined with medication for mild cognitive impairment: a systematic review and meta-analysis protocol
Introduction: Cognitive impairment is a global health crisis, which reduces quality of life and adds to the socio-economic burden. Previous meta-analyses have shown that the combination of acupuncture and conventional Western medicine may offer advantages over drug therapy alone. However, uncertainties remain regarding the scope and timeliness of the evidence search, the use of outdated risk-of-bias assessment tools, safety and long-term outcomes, and specific clinical value. Therefore, this study will conduct an updated systematic review and meta-analysis aimed at evaluating the clinical efficacy of acupuncture combined with medication for patients with mild cognitive impairment (MCI), with the hope of providing guidance for optimizing clinical decision-making. Methods and analysis: Search 9 databases (PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure, Wanfang Data, VIP, China Biology Medicine disc, Scopus) from the start date to July 2026. We will also search trial registries and gray literature sources. Include randomized controlled trials comparing acupuncture combined with medication versus medication alone in patients with MCI. The primary outcomes will be the Montreal Cognitive Assessment Scale (MoCA) and the Mini-Mental State Examination (MMSE). Secondary outcomes included the Modified Barthel Index (MBI), Rey Auditory Verbal Learning Test (RAVLT), Digit Span Test, and Adverse Events (AE). Two researchers will independently conduct selection, extraction, and RoB 2 bias risk assessment. The GRADE framework will be used to assess the quality of evidence. Weighted mean differences (MD) and standardized mean differences (SMD) will be used for continuous outcomes. Relative risks (RRs)/odds ratios (ORs) with 95% confidence intervals (CIs) are going to be used for categorical data. Heterogeneity sources will be explored through sensitivity analysis and subgroup analysis. The publication bias will be assessed through funnel plots and Egger’s test. Discussion: Comprehensive evidence to optimize clinical decision-making and treatment regarding the efficacy of acupuncture and pharmacotherapy in cognitive impairment. Systematic review registration: PROSPERO CRD420261367845
- 22 August 2026
- Published by Springer Nature in Systematic Reviews
- Vol. 15 (1) , 238
Open AccessEffectiveness of acupuncture combined with medication for mild cognitive impairment: a systematic review and meta-analysis protocol
Introduction: Cognitive impairment is a global health crisis, which reduces quality of life and adds to the socio-economic burden. Previous meta-analyses have shown that the combination of acupuncture and conventional Western medicine may offer advantages over drug therapy alone. However, uncertainties remain regarding the scope and timeliness of the evidence search, the use of outdated risk-of-bias assessment tools, safety and long-term outcomes, and specific clinical value. Therefore, this study will conduct an updated systematic review and meta-analysis aimed at evaluating the clinical efficacy of acupuncture combined with medication for patients with mild cognitive impairment (MCI), with the hope of providing guidance for optimizing clinical decision-making. Methods and analysis: Search 9 databases (PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure, Wanfang Data, VIP, China Biology Medicine disc, Scopus) from the start date to July 2026. We will also search trial registries and gray literature sources. Include randomized controlled trials comparing acupuncture combined with medication versus medication alone in patients with MCI. The primary outcomes will be the Montreal Cognitive Assessment Scale (MoCA) and the Mini-Mental State Examination (MMSE). Secondary outcomes included the Modified Barthel Index (MBI), Rey Auditory Verbal Learning Test (RAVLT), Digit Span Test, and Adverse Events (AE). Two researchers will independently conduct selection, extraction, and RoB 2 bias risk assessment. The GRADE framework will be used to assess the quality of evidence. Weighted mean differences (MD) and standardized mean differences (SMD) will be used for continuous outcomes. Relative risks (RRs)/odds ratios (ORs) with 95% confidence intervals (CIs) are going to be used for categorical data. Heterogeneity sources will be explored through sensitivity analysis and subgroup analysis. The publication bias will be assessed through funnel plots and Egger’s test. Discussion: Comprehensive evidence to optimize clinical decision-making and treatment regarding the efficacy of acupuncture and pharmacotherapy in cognitive impairment. Systematic review registration: PROSPERO CRD420261367845
- Open Access
- 7 August 2026
- Published by Wolters Kluwer Health in Guidelines and Standards of Chinese Medicine
- Vol. 4 (3) , 192-198
Interpretation of technical operation standards for traditional Chinese medicine health preservation and wellness services (nonmedical)-Guasha
Guasha, an external therapeutic modality in traditional Chinese medicine (TCM), is grounded in meridian and acupoint theory and demonstrates favorable preventive and therapeutic effects on painful conditions, degenerative bone and joint diseases, and other disorders. With increasing health awareness among the public, scraping therapy has gained widespread popularity owing to its simplicity, ease of application, and notable efficacy. However, the lack of unified technical standards and norms for TCM health care services such as Guasha gives rise to safety hazards and inconsistent therapeutic effectiveness. To standardize the practice of Guasha, the China Health and Wellness Service Center, the Institute of Basic Theory of Traditional Chinese Medicine at the China Academy of Traditional Chinese Medicine, Hunan University of Traditional Chinese Medicine, and other institutions jointly developed the Technical Operation Standards for Traditional Chinese Medicine Health Preservation and Wellness Services (Non-Medical)-Guasha (TOSG). Referencing the latest advances in TCM scraping therapy, this standard provides norms and guidance for the scraping procedure and its appropriate scope of application. This article summarizes and interprets the core content of the standard, with the aim of clarifying the indications and contraindications of Guasha, guiding correct operational methods, ensuring operational safety and hygiene, safeguarding the physical and mental health of recipients, and improving overall service quality. The formulation and promotion of this standard are conducive to advancing the standardized and regulated development of Guasha.
- 7 August 2026
- Published by Wolters Kluwer Health in Guidelines and Standards of Chinese Medicine
- Vol. 4 (3) , 192-198
Open AccessInterpretation of technical operation standards for traditional Chinese medicine health preservation and wellness services (nonmedical)-Guasha
Guasha, an external therapeutic modality in traditional Chinese medicine (TCM), is grounded in meridian and acupoint theory and demonstrates favorable preventive and therapeutic effects on painful conditions, degenerative bone and joint diseases, and other disorders. With increasing health awareness among the public, scraping therapy has gained widespread popularity owing to its simplicity, ease of application, and notable efficacy. However, the lack of unified technical standards and norms for TCM health care services such as Guasha gives rise to safety hazards and inconsistent therapeutic effectiveness. To standardize the practice of Guasha, the China Health and Wellness Service Center, the Institute of Basic Theory of Traditional Chinese Medicine at the China Academy of Traditional Chinese Medicine, Hunan University of Traditional Chinese Medicine, and other institutions jointly developed the Technical Operation Standards for Traditional Chinese Medicine Health Preservation and Wellness Services (Non-Medical)-Guasha (TOSG). Referencing the latest advances in TCM scraping therapy, this standard provides norms and guidance for the scraping procedure and its appropriate scope of application. This article summarizes and interprets the core content of the standard, with the aim of clarifying the indications and contraindications of Guasha, guiding correct operational methods, ensuring operational safety and hygiene, safeguarding the physical and mental health of recipients, and improving overall service quality. The formulation and promotion of this standard are conducive to advancing the standardized and regulated development of Guasha.
- Open Access
- 7 August 2026
- Published by Wolters Kluwer Health in Guidelines and Standards of Chinese Medicine
- Vol. 4 (3) , 184-191
Interpretation of technical operation specifications of traditional Chinese medicine health care services (nonmedical)—Tuina
On December 27, 2023, the China Association of Chinese Medicine published the group standard titled Technical Operation Specifications of Traditional Chinese Medicine Health Care Services (Non-Medical)—Tuina (T/CACM 1560.1—2023). The proposal was initiated by the Zhonghe Subhealth Service Center, and was subsequently drafted by multiple industry experts. In addition, the drafting process involved several institutions, including Hunan Medical University and Hunan University of Chinese Medicine. Comprehensive regulations have been formulated, delineating the preparatory measures before operation, operational procedures and requirements, post-Tuina management, precautions, and contraindications associated with Tuina services. The objective of this study is to standardize the technical operations of Tuina in traditional Chinese medicine health care services, thereby ensuring the safety and efficacy of the services. This article provides an interpretation of the main contents of the standard, with the expectation of offering standardized guidance for traditional Chinese medicine health care services and enhancing the service quality.
- 7 August 2026
- Published by Wolters Kluwer Health in Guidelines and Standards of Chinese Medicine
- Vol. 4 (3) , 184-191
Open AccessInterpretation of technical operation specifications of traditional Chinese medicine health care services (nonmedical)—Tuina
On December 27, 2023, the China Association of Chinese Medicine published the group standard titled Technical Operation Specifications of Traditional Chinese Medicine Health Care Services (Non-Medical)—Tuina (T/CACM 1560.1—2023). The proposal was initiated by the Zhonghe Subhealth Service Center, and was subsequently drafted by multiple industry experts. In addition, the drafting process involved several institutions, including Hunan Medical University and Hunan University of Chinese Medicine. Comprehensive regulations have been formulated, delineating the preparatory measures before operation, operational procedures and requirements, post-Tuina management, precautions, and contraindications associated with Tuina services. The objective of this study is to standardize the technical operations of Tuina in traditional Chinese medicine health care services, thereby ensuring the safety and efficacy of the services. This article provides an interpretation of the main contents of the standard, with the expectation of offering standardized guidance for traditional Chinese medicine health care services and enhancing the service quality.
- Open Access
- 4 August 2026
- Published by Wolters Kluwer Health in Guidelines and Standards of Chinese Medicine
- Vol. 4 (3) , 173-178
Technical operation specifications for traditional Chinese medicine health and wellness services (non-medical)—Cupping
With the popularization of traditional Chinese medicine (TCM) health and wellness services, standardizing the operation of cupping techniques has become key to enhancing service quality and safety. The Technical Operation Specifications for Traditional Chinese Medicine Health and Wellness Services (Non-Medical)—Cupping aims to provide standardized operational guidance for nonmedical TCM health and wellness service institutions and their practitioners. This article provides a detailed interpretation of the pretreatment preparation, operation steps and requirements, posttreatment care, precautions, and contraindications during the cupping operation process. Through an in-depth interpretation of the Specifications, this article aims to improve the standardization of cupping techniques, enhance the safety and effectiveness of services, and better serve the health needs of the general public.
- 4 August 2026
- Published by Wolters Kluwer Health in Guidelines and Standards of Chinese Medicine
- Vol. 4 (3) , 173-178
Open AccessTechnical operation specifications for traditional Chinese medicine health and wellness services (non-medical)—Cupping
With the popularization of traditional Chinese medicine (TCM) health and wellness services, standardizing the operation of cupping techniques has become key to enhancing service quality and safety. The Technical Operation Specifications for Traditional Chinese Medicine Health and Wellness Services (Non-Medical)—Cupping aims to provide standardized operational guidance for nonmedical TCM health and wellness service institutions and their practitioners. This article provides a detailed interpretation of the pretreatment preparation, operation steps and requirements, posttreatment care, precautions, and contraindications during the cupping operation process. Through an in-depth interpretation of the Specifications, this article aims to improve the standardization of cupping techniques, enhance the safety and effectiveness of services, and better serve the health needs of the general public.
- Open Access
- 27 July 2026
- Published by Wolters Kluwer Health in Guidelines and Standards of Chinese Medicine
- Vol. 4 (3) , 179-183
Interpretation of the technical operation specifications for traditional Chinese medicine health care services (non-medical) - Moxibustion
With the increasing public emphasis on health, the traditional Chinese medicine (TCM) health care service industry has undergone rapid development, rendering the establishment of industry technical operation specifications particularly crucial. The Technical Operation Specifications for Traditional Chinese Medicine Health Care Services (Nonmedical)—Moxibustion has been issued by the China Association of Chinese Medicine to standardize the operational procedures of moxibustion techniques in TCM health care services, enhancing service quality, and ensuring the safety and effectiveness of moxibustion practices. This article provides an in-depth interpretation of core elements, including the definition of moxibustion, basic requirements, operational procedures, precautions, and contraindications, thereby offering professional guidance for the application of moxibustion in the field of health care and wellness.
- 27 July 2026
- Published by Wolters Kluwer Health in Guidelines and Standards of Chinese Medicine
- Vol. 4 (3) , 179-183
Open AccessInterpretation of the technical operation specifications for traditional Chinese medicine health care services (non-medical) - Moxibustion
With the increasing public emphasis on health, the traditional Chinese medicine (TCM) health care service industry has undergone rapid development, rendering the establishment of industry technical operation specifications particularly crucial. The Technical Operation Specifications for Traditional Chinese Medicine Health Care Services (Nonmedical)—Moxibustion has been issued by the China Association of Chinese Medicine to standardize the operational procedures of moxibustion techniques in TCM health care services, enhancing service quality, and ensuring the safety and effectiveness of moxibustion practices. This article provides an in-depth interpretation of core elements, including the definition of moxibustion, basic requirements, operational procedures, precautions, and contraindications, thereby offering professional guidance for the application of moxibustion in the field of health care and wellness.
- Open Access
Molecular Basis of Glia–ECM Interplay in Central Nervous System Homeostasis and Plasticity
Interactions between glial cells and the central nervous system (CNS) extracellular matrix (ECM) maintain neural homeostasis and plasticity. In contrast to traditional reviews focusing on biochemistry, this work summarizes the structural and mechanical properties of major ECM subtypes, and illustrates how mechanical and biochemical signals jointly regulate glial activity via key mechanosensitive pathways. Glia in turn dynamically remodel ECM, forming a reciprocal regulatory network. This paper also analyzes characteristic mechanical disorders in Alzheimer’s disease, multiple sclerosis and traumatic brain injury, and addresses targeted therapeutic strategies. Current research challenges and emerging interdisciplinary directions are also discussed. This review provides a valuable reference for exploring neurological disease mechanisms and developing new therapies.
Open AccessMolecular Basis of Glia–ECM Interplay in Central Nervous System Homeostasis and Plasticity
Interactions between glial cells and the central nervous system (CNS) extracellular matrix (ECM) maintain neural homeostasis and plasticity. In contrast to traditional reviews focusing on biochemistry, this work summarizes the structural and mechanical properties of major ECM subtypes, and illustrates how mechanical and biochemical signals jointly regulate glial activity via key mechanosensitive pathways. Glia in turn dynamically remodel ECM, forming a reciprocal regulatory network. This paper also analyzes characteristic mechanical disorders in Alzheimer’s disease, multiple sclerosis and traumatic brain injury, and addresses targeted therapeutic strategies. Current research challenges and emerging interdisciplinary directions are also discussed. This review provides a valuable reference for exploring neurological disease mechanisms and developing new therapies.
- Open Access
- 15 June 2026
- Published by IMR Press in Journal of Integrative Neuroscience
- Vol. 25 (6) , 48660
Exploring the Microbiome-Kynurenine Axis in Mild Cognitive Impairment: From Gut to Brain
Mild cognitive impairment (MCI) represents a critical prodromal stage of Alzheimer’s disease. This review synthesizes current evidence to present a coherent pathological cascade driving MCI progression: gut microbiota dysbiosis (e.g., enrichment of Prevotella and depletion of Akkermansia) triggers a butyrate deficit and compromise of intestinal integrity, leading to systemic inflammation. This inflammatory milieu upregulates indoleamine 2,3-dioxygenase 1 (IDO1), shifting tryptophan metabolism toward the kynurenine pathway and resulting in the dominance of neurotoxic branches (3-hydroxykynurenine [3-HK], quinolinic acid [QUIN]) over neuroprotective kynurenic acid (KYNA). This metabolic imbalance promotes N-methyl-D-aspartate (NMDA) receptor-mediated excitotoxicity, oxidative stress, and neuroinflammation, which collectively precipitate synaptic dysfunction and cognitive decline. We explicitly highlight this “gut-immune-metabolic” vicious cycle as the core framework of MCI pathology. Targeting this cycle through a dual strategy—restoring microbial diversity and pharmacologically inhibiting the IDO1/kynurenine 3-monooxygenase (KMO) enzymes—represents a promising therapeutic approach to delay the transition from MCI to dementia.
- 15 June 2026
- Published by IMR Press in Journal of Integrative Neuroscience
- Vol. 25 (6) , 48660
Open AccessExploring the Microbiome-Kynurenine Axis in Mild Cognitive Impairment: From Gut to Brain
Mild cognitive impairment (MCI) represents a critical prodromal stage of Alzheimer’s disease. This review synthesizes current evidence to present a coherent pathological cascade driving MCI progression: gut microbiota dysbiosis (e.g., enrichment of Prevotella and depletion of Akkermansia) triggers a butyrate deficit and compromise of intestinal integrity, leading to systemic inflammation. This inflammatory milieu upregulates indoleamine 2,3-dioxygenase 1 (IDO1), shifting tryptophan metabolism toward the kynurenine pathway and resulting in the dominance of neurotoxic branches (3-hydroxykynurenine [3-HK], quinolinic acid [QUIN]) over neuroprotective kynurenic acid (KYNA). This metabolic imbalance promotes N-methyl-D-aspartate (NMDA) receptor-mediated excitotoxicity, oxidative stress, and neuroinflammation, which collectively precipitate synaptic dysfunction and cognitive decline. We explicitly highlight this “gut-immune-metabolic” vicious cycle as the core framework of MCI pathology. Targeting this cycle through a dual strategy—restoring microbial diversity and pharmacologically inhibiting the IDO1/kynurenine 3-monooxygenase (KMO) enzymes—represents a promising therapeutic approach to delay the transition from MCI to dementia.
- Open Access
- 4 May 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1) , 2665513
Impact of infrared moxibustion for patients with mild hyperlipidemia: a protocol for a randomized controlled trial
Hyperlipidemia serves as a significant risk factor for cardiovascular diseases and cognitive impairment, making early intervention and management highly necessary. Infrared moxibustion, a modern complementary and alternative therapy, currently lacks high-quality clinical research to substantiate its efficacy and underlying mechanisms. Therefore, this study aims to evaluate the effects of infrared moxibustion on blood lipid levels in patients with hyperlipidemia, and to explore its potential mechanisms by analyzing changes in gut microbiota and their metabolites, as well as alterations in brain gray matter volume. This study will recruit 158 patients with mild hyperlipidemia and randomly assign them to either a genuine infrared moxibustion group or a sham infrared moxibustion group. The intervention will be administered twice weekly for a total of 8 weeks. Blood lipid levels, Montreal Cognitive Assessment scores, Hamilton Depression Rating Scale scores, Hamilton Anxiety Scale scores, and Pittsburgh Sleep Quality Index scores will be compared between the two groups before treatment, and at 4, 8, and 12 weeks post-treatment. Additionally, changes in gut microbiota, the gut microbiota metabolite trimethylamine N-oxide (TMAO), and brain gray matter volume will be detected and compared between the two groups before treatment and at 8 weeks post-treatment (See Graphic Abstract).
- 4 May 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1) , 2665513
Open AccessImpact of infrared moxibustion for patients with mild hyperlipidemia: a protocol for a randomized controlled trial
Hyperlipidemia serves as a significant risk factor for cardiovascular diseases and cognitive impairment, making early intervention and management highly necessary. Infrared moxibustion, a modern complementary and alternative therapy, currently lacks high-quality clinical research to substantiate its efficacy and underlying mechanisms. Therefore, this study aims to evaluate the effects of infrared moxibustion on blood lipid levels in patients with hyperlipidemia, and to explore its potential mechanisms by analyzing changes in gut microbiota and their metabolites, as well as alterations in brain gray matter volume. This study will recruit 158 patients with mild hyperlipidemia and randomly assign them to either a genuine infrared moxibustion group or a sham infrared moxibustion group. The intervention will be administered twice weekly for a total of 8 weeks. Blood lipid levels, Montreal Cognitive Assessment scores, Hamilton Depression Rating Scale scores, Hamilton Anxiety Scale scores, and Pittsburgh Sleep Quality Index scores will be compared between the two groups before treatment, and at 4, 8, and 12 weeks post-treatment. Additionally, changes in gut microbiota, the gut microbiota metabolite trimethylamine N-oxide (TMAO), and brain gray matter volume will be detected and compared between the two groups before treatment and at 8 weeks post-treatment (See Graphic Abstract).
- Open Access
- 1 May 2026
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 21, 1-25
Plant-Derived Nanovesicles for Ischemic Stroke Therapy via the Gut Microbiota-Gut-Brain Axis: A New Paradigm of Systemic Regulation
Ischemic stroke (IS) is a globally significant disease with complex pathological mechanisms. Traditional therapeutic strategies centered on central nervous system-targeted delivery face substantial limitations due to the presence of the blood-brain barrier (BBB) and the multifactorial nature of the disease. In recent years, the gut microbiota-gut-brain axis, which elucidates the multi-pathway dialogue between the gut and the brain, has provided a novel systemic intervention perspective for IS treatment. In this context, Plant-Derived Nanovesicles (PDNVs), a class of natural nanocarriers derived from plants, have emerged prominently due to their inherent multi-component synergistic properties, excellent biocompatibility, and cross-kingdom regulatory capabilities. Critically, IS itself rapidly induces gut dysbiosis and barrier disruption, creating a vicious cycle that amplifies neuroinflammation—a pathological feature shared with other inflammatory conditions such as colitis and Inflammatory bowel disease. In this context, PDNVs, a class of natural nanocarriers derived from plants, have emerged prominently due to their inherent multi-component synergistic properties, excellent biocompatibility, and cross-kingdom regulatory capabilities. Drawing on mechanistic insights from these related disease models, this article systematically discusses the multi-level integrated mechanism of PDNVs as novel “functional messengers”, involving reshaping the gut microenvironment, mediating systemic metabolic-immune signals, and ultimately synergistically activating the central nervous repair network, thereby offering a new paradigm for IS therapy. This review not only summarizes the mechanisms of action of PDNVs but also systematically constructs a framework and strategy for their translation from experimental research to clinical application. Highlighting critical hurdles such as the need for standardized production and rigorous quality control to ensure batch-to-batch consistency.
- 1 May 2026
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 21, 1-25
Open AccessPlant-Derived Nanovesicles for Ischemic Stroke Therapy via the Gut Microbiota-Gut-Brain Axis: A New Paradigm of Systemic Regulation
Ischemic stroke (IS) is a globally significant disease with complex pathological mechanisms. Traditional therapeutic strategies centered on central nervous system-targeted delivery face substantial limitations due to the presence of the blood-brain barrier (BBB) and the multifactorial nature of the disease. In recent years, the gut microbiota-gut-brain axis, which elucidates the multi-pathway dialogue between the gut and the brain, has provided a novel systemic intervention perspective for IS treatment. In this context, Plant-Derived Nanovesicles (PDNVs), a class of natural nanocarriers derived from plants, have emerged prominently due to their inherent multi-component synergistic properties, excellent biocompatibility, and cross-kingdom regulatory capabilities. Critically, IS itself rapidly induces gut dysbiosis and barrier disruption, creating a vicious cycle that amplifies neuroinflammation—a pathological feature shared with other inflammatory conditions such as colitis and Inflammatory bowel disease. In this context, PDNVs, a class of natural nanocarriers derived from plants, have emerged prominently due to their inherent multi-component synergistic properties, excellent biocompatibility, and cross-kingdom regulatory capabilities. Drawing on mechanistic insights from these related disease models, this article systematically discusses the multi-level integrated mechanism of PDNVs as novel “functional messengers”, involving reshaping the gut microenvironment, mediating systemic metabolic-immune signals, and ultimately synergistically activating the central nervous repair network, thereby offering a new paradigm for IS therapy. This review not only summarizes the mechanisms of action of PDNVs but also systematically constructs a framework and strategy for their translation from experimental research to clinical application. Highlighting critical hurdles such as the need for standardized production and rigorous quality control to ensure batch-to-batch consistency.
- Open Access
- 30 April 2026
- Published by The Korean Society of Neurogastroenterology and Motility in Journal of Neurogastroenterology and Motility
- Vol. 32 (2) , 276-289
Patients' Knowledge, Attitudes, and Practices Regarding Non-pharmacological Treatments for Irritable Bowel Syndrome
Chengwen Li, Qiong Liu, Jianan Cao, Xuan Xu, Haolong He, Yingchun Huang, Xinye Liu, Rong Luo, Xiaorong Chang, and Mi Liu. J Neurogastroenterol Motil 2026;32:276-89. https://doi.org/10.5056/jnm25147
- 30 April 2026
- Published by The Korean Society of Neurogastroenterology and Motility in Journal of Neurogastroenterology and Motility
- Vol. 32 (2) , 276-289
Open AccessPatients' Knowledge, Attitudes, and Practices Regarding Non-pharmacological Treatments for Irritable Bowel Syndrome
Chengwen Li, Qiong Liu, Jianan Cao, Xuan Xu, Haolong He, Yingchun Huang, Xinye Liu, Rong Luo, Xiaorong Chang, and Mi Liu. J Neurogastroenterol Motil 2026;32:276-89. https://doi.org/10.5056/jnm25147